Cite
HARVARD Citation
De Luca, L. et al. (n.d.). Hepatitis C patients with any degree of portal hypertension are at risk to develop serious adverse effect to direct-acting antiviral therapies. Digestive and liver disease. pp. e234-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
De Luca, L. et al. (n.d.). Hepatitis C patients with any degree of portal hypertension are at risk to develop serious adverse effect to direct-acting antiviral therapies. Digestive and liver disease. pp. e234-. [Online].